Author:
Bowen Joanne M.,Gibson Rachel J.,Cummins Adrian G.,Tyskin Anna,Keefe Dorothy M. K.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference51 articles.
1. Alimonti A, Gelibter A, Pavese I, Satta F, Cognetti F, Ferretti G et al (2004) New approaches to prevent intestinal toxicity of irinotecan-based regimens. Cancer Treat Rev 30(6):555–562
2. Altmann SW, Davis HR Jr, Zhu LJ, Yao X, Hoos LM, Tetzloff G et al (2004) Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science 303(5661): 1201–1204
3. Ando Y, Hasegawa Y (2005) Clinical pharmacogenetics of irinotecan (CPT-11). Drug Metab Rev 37(3):565–574
4. Barisani D, Parafioriti A, Bardella MT, Zoller H, Conte D, Armiraglio E et al (2004) Adaptive changes of duodenal iron transport proteins in celiac disease. Physiol Genomics 17(3):316–325
5. Boushey RP, Yusta B, Drucker DJ (2001) Glucagon-like peptide (GLP)-2 reduces chemotherapy-associated mortality and enhances cell survival in cells expressing a transfected GLP-2 receptor. Cancer Res 61(2):687–693
Cited by
37 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献